Back

Physicians’ Education Resource

  • Carcinoma, Non-Small-Cell Lung
  • Immunotherapy

Show Me the Data: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable, Early-Stage NSCLC

This online, on-demand virtual symposium brings together renowned experts in early-stage, resectable, non small cell lung cancer (NSCLC). In this educational program, these experts lead case-based panel discussions on the latest clinical advances in managing resectable NSCLC with immunotherapy and targeted treatments. The expert panel also shares their perspectives on the latest data and clinical pearls from their practices in managing early-stage, resectable NSCLC. This educational activity is an archive of the live symposium held on January 29, 2026.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME · seen on gotoper.com

  • Case-based learning
  • includes On-demand / recorded video
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Feb 10, 2026
  • Last day to claim credit
    Feb 11, 2027 4 months left